← FDA DRUG APPROVALS

FDA ANDA · ANDA071438

RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER

Sponsor: HOSPIRA

APPLICATION
ANDA071438
TYPE
ANDA
ORIGINAL APPROVAL
1991-01-22
LATEST ACTION
1998-03-09
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINERDiscontinued
RITODRINE HYDROCHLORIDE 30MG/100ML · INJECTABLE · INJECTION

Approval history

1998-03-09Labeling · Supplement 7AP
1996-09-10Manufacturing (CMC) · Supplement 5AP
1996-07-22Manufacturing (CMC) · Supplement 2AP
1995-11-02Manufacturing (CMC) · Supplement 4AP
1992-10-08Manufacturing (CMC) · Supplement 1AP
1991-01-22OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →